Related Experiment Video
Updated: Nov 17, 2025

An Efficient and High Yield Method for Isolation of Mouse Dendritic Cell Subsets
Published on: April 18, 2016
Soluble CD83 Regulates Dendritic Cell-T Cell Immunological Synapse Formation by Disrupting Rab1a-Mediated F-Actin
Wei Lin1, Shuping Zhou1, Meng Feng1
1Institute of Basic Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Shandong First Medical University & Shandong Academy of Medical Science, Jinan, China.
Insights
Soluble CD83 (sCD83) inhibits T cell activation by disrupting dendritic cell (DC) cytoskeletal rearrangements and DC-T cell contact. This pathway offers potential for new immunosuppressive therapies for autoimmune diseases.
Area of Science:
- Immunology
- Cell Biology
- Autoimmune Disease Research
Background:
- Dendritic cell-T cell (DC-T) interactions are crucial for T cell activation and immune responses.
- Cytoskeletal regulation in DCs significantly influences DC-T cell contact and subsequent T cell activation.
- Inhibitory factors affecting DC cytoskeletal regulation are not well understood.
Purpose of the Study:
- To investigate the role of soluble CD83 (sCD83) in modulating DC-T cell interactions and T cell activation.
- To elucidate the molecular mechanisms by which sCD83 affects DC cytoskeletal dynamics and synapse formation.
- To evaluate the therapeutic potential of sCD83 in an animal model of autoimmune disease.
Main Methods:
- Treatment of DCs with sCD83.
- Assessment of DC-T cell contact, synapse formation, and T cell activation.
- Analysis of F-actin rearrangements, MHC-II expression and localization, and Rab1a GTP-binding activity.
- Evaluation of sCD83-treated DCs in a mouse model of experimental autoimmune uveitis.
Main Results:
- sCD83 inhibited T cell activation by reducing DC-T cell contact and synapse formation.
- sCD83 disrupted F-actin rearrangements in DCs, altering MHC-II expression/localization and synapse formation.
- sCD83 decreased Rab1a GTP-binding activity, impacting LRRK2 colocalization and F-actin rearrangements.
- sCD83-treated DCs ameliorated experimental autoimmune uveitis symptoms in mice.
Conclusions:
- sCD83 negatively regulates DC-T cell contact and T cell activation through cytoskeletal disruption.
- A novel signaling pathway involving sCD83, Rab1a, LRRK2, and F-actin impacts DC function.
- sCD83 demonstrates therapeutic potential for treating autoimmune diseases like uveitis.
Abstract:
Dendritic cell-T cell (DC-T) contacts play an important role in T cell activation, clone generation, and development. Regulating the cytoskeletal protein rearrangement of DCs can modulate DC-T contact and affect T cell activation. However, inhibitory factors on cytoskeletal regulation in DCs remain poorly known. We showed that a soluble form of CD83 (sCD83) inhibited T cell activation by decreasing DC-T contact and synapse formation between DC and T cells. This negative effect of sCD83 on DCs was mediated by disruption of F-actin rearrangements, leading to alter expression and localization of major histocompatibility complex class II (MHC-II) and immunological synapse formation between DC and T cells. Furthermore, sCD83 was found to decrease GTP-binding activity of Rab1a, which further decreased colocalization and expression of LRRK2 and F-actin rearrangements in DCs, leading to the loss of MHC-II at DC-T synapses and reduced DC-T synapse formation. Further, sCD83-treated DCs alleviated symptoms of experimental autoimmune uveitis in mice and decreased the number of T cells in the eyes and lymph nodes of these animals. Our findings demonstrate a novel signaling pathway of sCD83 on regulating DC-T contact, which may be harnessed to develop new immunosuppressive therapeutics for autoimmune disease.
Related Concept Videos
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Rab Cascades

